EUVIMEDEUVIMED entdecken
Crossref

Biomarkers and Risk Stratification in the Prognostication of Immune Checkpoint Inhibitors-associated Myocarditis

Yin Qian, Zhou Yuntao, Chen Weiwu, Kong Yuehong, Zhang Liyuan

Diseases & Research · 2026 · 6 (2) · 92-101

DOI: 10.54457/dr.202601004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases & Research, 2026. Verfasst von Yin Qian und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Qian, Y., Yuntao, Z., Weiwu, C., Yuehong, K., & Liyuan, Z. (2026). Biomarkers and Risk Stratification in the Prognostication of Immune Checkpoint Inhibitors-associated Myocarditis. Diseases & Research, 6(2), 92-101. https://doi.org/10.54457/dr.202601004

Vancouver

Qian Y, Yuntao Z, Weiwu C, Yuehong K, Liyuan Z. Biomarkers and Risk Stratification in the Prognostication of Immune Checkpoint Inhibitors-associated Myocarditis. Diseases & Research. 2026;6(2):92-101. doi:10.54457/dr.202601004

BibTeX
@article{Qian2026,
  author = {Qian, Yin and Yuntao, Zhou and Weiwu, Chen and Yuehong, Kong and Liyuan, Zhang},
  title = {Biomarkers and Risk Stratification in the Prognostication of Immune Checkpoint Inhibitors-associated Myocarditis},
  journal = {Diseases & Research},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {92--101},
  doi = {10.54457/dr.202601004}
}
Kostenlos starten →